TrialJAMA2019

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.

Richard K Burt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.